Works matching DE "DARBEPOETIN alfa"

Results: 84
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥10 g/dL: an exploratory analysis of a phase 3 trial.

    Published in:
    Medical Oncology, 2012, v. 29, n. 3, p. 2291, doi. 10.1007/s12032-011-0103-x
    By:
    • Canon, Jean-Luc;
    • Vansteenkiste, Johan;
    • Hedenus, Michael;
    • Gascon, Pere;
    • Bokemeyer, Carsten;
    • Ludwig, Heinz;
    • Vermorken, Jan;
    • Legg, Jason;
    • Pujol, Beatriz;
    • Bridges, Ken
    Publication type:
    Article
    11
    12
    13

    High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.

    Published in:
    Annals of Hematology, 2013, v. 92, n. 5, p. 621, doi. 10.1007/s00277-013-1686-4
    By:
    • Kelaidi, C.;
    • Beyne-Rauzy, O.;
    • Braun, T.;
    • Sapena, R.;
    • Cougoul, P.;
    • Adès, L.;
    • Pillard, F.;
    • Lambert, C.;
    • Charniot, J.;
    • Guerci, A.;
    • Choufi, B.;
    • Stamatoullas, A.;
    • Slama, B.;
    • Renzis, B.;
    • Ame, S.;
    • Damaj, G.;
    • Boyer, F.;
    • Chaury, M.;
    • Legros, L.;
    • Cheze, S.
    Publication type:
    Article
    14
    15
    16

    Pharmacology of darbepoetin alfa.

    Published in:
    Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_4, p. iv2, doi. 10.1093/ndt/gfm160
    By:
    • Macdougall, Iain C.;
    • Padhi, Desmond;
    • Jang, Graham
    Publication type:
    Article
    17

    Foreword.

    Published in:
    Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_4, p. iv1, doi. 10.1093/ndt/gfm159
    By:
    • Carrera, Fernando
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation.

    Published in:
    Drugs in R&D, 2017, v. 17, n. 3, p. 389, doi. 10.1007/s40268-017-0188-6
    By:
    • Satoru Oka;
    • Yoko Obata;
    • Kenta Torigoe;
    • Miki Torigoe;
    • Shinichi Abe;
    • Kumiko Muta;
    • Yuki Ota;
    • Mineaki Kitamura;
    • Satoko Kawasaki;
    • Misaki Hirose;
    • Tadashi Uramatsu;
    • Hiroshi Yamashita;
    • Hideyuki Arai;
    • Hiroshi Mukae;
    • Tomoya Nishino
    Publication type:
    Article
    34
    35
    36

    Maintenance of target hemoglobin level in stable hemodialysis patients constitutes a theoretical task: a historical prospective study: New strategies to prevent cardiovascular risk in chronic kidney disease.

    Published in:
    Kidney International, 2008, v. 74, p. S82, doi. 10.1038/ki.2008.524
    By:
    • Portolés, José M.;
    • de Francisco, Ángel L.M.;
    • Górriz, José L.;
    • Martínez-Castelao, Alberto;
    • López-Gómez, Juan M.;
    • Arias, Manuel;
    • de la Cruz, Juan J.;
    • Cases, Aleix;
    • Fernández, Evaristo;
    • Aljama, Pedro
    Publication type:
    Article
    37
    38
    39

    Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

    Published in:
    Clinical & Experimental Nephrology, 2018, v. 22, n. 1, p. 78, doi. 10.1007/s10157-017-1427-4
    By:
    • Kato, Hideki;
    • Nangaku, Masaomi;
    • Hirakata, Hideki;
    • Wada, Takashi;
    • Hayashi, Terumasa;
    • Sato, Hiroshi;
    • Yamazaki, Yasushi;
    • Masaki, Takao;
    • Kagimura, Tatsuo;
    • Yamamoto, Hiroyasu;
    • Hase, Hiroki;
    • Kamouchi, Masahiro;
    • Imai, Enyu;
    • Mizuno, Kyoichi;
    • Iwasaki, Manabu;
    • Akizawa, Tadao;
    • Tsubakihara, Yoshiharu;
    • Maruyama, Shoichi;
    • Narita, Ichiei
    Publication type:
    Article
    40

    Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).

    Published in:
    Clinical & Experimental Nephrology, 2016, v. 20, n. 1, p. 71, doi. 10.1007/s10157-015-1133-z
    By:
    • Imai, Enyu;
    • Maruyama, Shoichi;
    • Nangaku, Masaomi;
    • Hirakata, Hideki;
    • Hayashi, Terumasa;
    • Narita, Ichiei;
    • Kono, Hideki;
    • Nakatani, Eiji;
    • Morita, Satoshi;
    • Tsubakihara, Yoshiharu;
    • Akizawa, Tadao
    Publication type:
    Article
    41
    42
    43
    44

    Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan.

    Published in:
    Clinical & Experimental Nephrology, 2013, v. 17, n. 4, p. 582, doi. 10.1007/s10157-012-0714-3
    By:
    • Hattori, Motoshi;
    • Matsunaga, Akira;
    • Akioka, Yuko;
    • Fujinaga, Shuichiro;
    • Nagai, Takuhito;
    • Uemura, Osamu;
    • Nakakura, Hyogo;
    • Ashida, Akira;
    • Kamei, Koichi;
    • Ito, Shuichi;
    • Yamada, Takuji;
    • Goto, Yoshimitsu;
    • Ohta, Toshiyuki;
    • Hisano, Masataka;
    • Komatsu, Yasuhiro;
    • Itami, Noritomo
    Publication type:
    Article
    45

    Different administration schedules of darbepoetin alfa affect oxidized and reduced glutathione levels to a similar extent in 5/6 nephrectomized rats.

    Published in:
    Clinical & Experimental Nephrology, 2013, v. 17, n. 4, p. 569, doi. 10.1007/s10157-012-0749-5
    By:
    • Monostori, Péter;
    • Kocsis, Gabriella;
    • Ökrös, Zsuzsanna;
    • Bencsik, Péter;
    • Czétényi, Orsolya;
    • Kiss, Zoltán;
    • Gellén, Balázs;
    • Bereczki, Csaba;
    • Ocsovszki, Imre;
    • Pipis, Judit;
    • Pálóczi, János;
    • Sárközy, Márta;
    • Török, Szilvia;
    • Varga, Ilona;
    • Kiss, István;
    • Fodor, Eszter;
    • Csont, Tamás;
    • Ferdinandy, Péter;
    • Túri, Sándor
    Publication type:
    Article
    46

    Erratum.

    Published in:
    2016
    Publication type:
    Correction Notice
    47
    48
    49

    Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study.

    Published in:
    Nephrology Dialysis Transplantation, 2016, v. 31, n. 12, p. 2073, doi. 10.1093/ndt/gfw047
    By:
    • Galle, Jan-Christoph;
    • Addison, Janet;
    • Suranyi, Michael G.;
    • Claes, Kathleen;
    • Di Giulio, Salvatore;
    • Guerin, Alain;
    • Herlitz, Hans;
    • Kiss, István;
    • Farouk, Mourad;
    • Manamley, Nick;
    • Wirnsberger, Gerhard;
    • Winearls, Christopher
    Publication type:
    Article
    50

    DIALYSIS ANAEMIA.

    Published in:
    Nephrology Dialysis Transplantation, 2014, v. 29, n. suppl_3, p. iii491, doi. 10.1093/ndt/gfu176
    Publication type:
    Article